Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Nvidia Moves Higher; Pfizer in Shutdown Flux; Rumble Rises

4:22
 
Share
 

Manage episode 518713341 series 3654950
Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

On this episode of Stock Movers:
- Nvidia (NVDA) shares are moving higher in the premarket session with the company paring some of its losses from last week. S&P 500 futures rose 1% after a group of Senate Democrats broke with their party on a procedural measure to help Republicans advance a funding bill. Nasdaq 100 contracts gained 1.5% after the underlying index suffered its worst week since April. Nvidia Corp. led gains among the Magnificent Seven tech stocks in premarket trading, rising more than 3%.
- Shares of Pfizer (PFE) edge higher in early trading, despite concerns as the US government shutdown approaches a resolution with no deal regarding healthcare subsidies. Meantime, Novo Nordisk's (NOVO) weekend decision to exit the bidding war for Metsera (MTSR) clears the way for Pfizer's amended offer of $86.25 per share -- or a total of up to $10 billion, which now requires formal Metsera shareholder approval at a November 13th meeting. The implied 10.1x EV-to-2030 consensus sales multiple is at the top end of recent Pharma-Biotech deals and highlights the continued significant interest of large-cap Pharma in clinical-stage obesity assets.
- Shares of YouTube competitor Rumble (RUM) soared ahead of the US market open, after the conservative video service agreed to push ahead with a deal for German data center operator Northern Data AG at a reduced price, after news of a tax probe jeopardized the transaction. Northern Data owners will receive 2.0281 Rumble Class A shares per share they tender, it said in a statement Monday. That’s equivalent to about $11.95 per share, or €10.32, using Rumble’s Friday closing price. Bloomberg News reported Sunday that the companies, which are both backed by stablecoin issuer Tether Holdings Ltd., were nearing a deal.

See omnystudio.com/listener for privacy information.

  continue reading

1204 episodes

Artwork
iconShare
 
Manage episode 518713341 series 3654950
Content provided by iHeartPodcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

On this episode of Stock Movers:
- Nvidia (NVDA) shares are moving higher in the premarket session with the company paring some of its losses from last week. S&P 500 futures rose 1% after a group of Senate Democrats broke with their party on a procedural measure to help Republicans advance a funding bill. Nasdaq 100 contracts gained 1.5% after the underlying index suffered its worst week since April. Nvidia Corp. led gains among the Magnificent Seven tech stocks in premarket trading, rising more than 3%.
- Shares of Pfizer (PFE) edge higher in early trading, despite concerns as the US government shutdown approaches a resolution with no deal regarding healthcare subsidies. Meantime, Novo Nordisk's (NOVO) weekend decision to exit the bidding war for Metsera (MTSR) clears the way for Pfizer's amended offer of $86.25 per share -- or a total of up to $10 billion, which now requires formal Metsera shareholder approval at a November 13th meeting. The implied 10.1x EV-to-2030 consensus sales multiple is at the top end of recent Pharma-Biotech deals and highlights the continued significant interest of large-cap Pharma in clinical-stage obesity assets.
- Shares of YouTube competitor Rumble (RUM) soared ahead of the US market open, after the conservative video service agreed to push ahead with a deal for German data center operator Northern Data AG at a reduced price, after news of a tax probe jeopardized the transaction. Northern Data owners will receive 2.0281 Rumble Class A shares per share they tender, it said in a statement Monday. That’s equivalent to about $11.95 per share, or €10.32, using Rumble’s Friday closing price. Bloomberg News reported Sunday that the companies, which are both backed by stablecoin issuer Tether Holdings Ltd., were nearing a deal.

See omnystudio.com/listener for privacy information.

  continue reading

1204 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play